Munafa Stock Market Course + Intraday & FNO calls 
Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Protagonist Therapeutics (PTGX)
Technical Analysis Report for NASDAQ stock PTGX Protagonist Therapeutics. Dated: 05 Oct 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics then click here. or read Experts views on Protagonist Therapeutics or Forecast & share price targets of Protagonist Therapeutics
Protagonist Therapeutics Opened at 139.96 and Closed at: 140.63, which is 0.41% of previous session's close. It moved within a range of 138.08 and 142.51
The session was a Bullish session with an average volume of 1273800, which is 40.31% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- The stock has shown an up move, and its mid term trend is also positive and in an uptrend.
- The stock has shown an up move, and its long term trend is also positive and in an uptrend.
A Dead cross was found 9 days back on mid term averages
Support for tomorrow is 139.36 and resistance for tomorrow is 143.79
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 138.3, 135.98 resistance for tomorrow's hourly charts is 142.73, 144.84
10 Day SMA for Protagonist Therapeutics (PTGX) is 140.72 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Protagonist Therapeutics (PTGX) is 142.86 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Protagonist Therapeutics (PTGX) is 145.07 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 130.93 and the stock is trading above these levels. This is a good sign for its long term trend
200 Day SMA Protagonist Therapeutics is 111.73 and stock is trading above these levels. This is a good sign for its long term trend
20 DMA of Protagonist Therapeutics is at 142.86 and 200 DMA is at 111.73, while 50 DMA and 100 DMA are at 145.07 and 130.93 respectively
Protagonist Therapeutics (PTGX) moving average of 20 SMA is at 142.86 and 20 EMA is at 142.53
| Date | Closing Price | 20 SMA | 20 EMA |
| 05 Mon Oct | 140.63 | 142.86 | 142.53 |
| 02 Fri Oct | 140.06 | 143.12 | 142.73 |
| 01 Thu Oct | 139.19 | 143.55 | 143.01 |
| 30 Wed Sep | 140.89 | 143.9 | 143.41 |
| 29 Tue Sep | 140.97 | 144.18 | 143.67 |
| 28 Mon Sep | 142.44 | 144.52 | 143.95 |
Protagonist Therapeutics (PTGX) moving average of 50 SMA is at 145.07 and 50 EMA is at 141.19
| Date | Closing Price | 50 SMA | 50 EMA |
| 05 Mon Oct | 140.63 | 145.07 | 141.19 |
| 02 Fri Oct | 140.06 | 144.98 | 141.21 |
| 01 Thu Oct | 139.19 | 144.9 | 141.26 |
| 30 Wed Sep | 140.89 | 144.83 | 141.34 |
| 29 Tue Sep | 140.97 | 144.72 | 141.36 |
| 28 Mon Sep | 142.44 | 144.66 | 141.38 |
Protagonist Therapeutics (PTGX) moving average of 100 SMA is at 130.93 and 100 EMA is at 132.34
| Date | Closing Price | 100 SMA | 100 EMA |
| 05 Mon Oct | 140.63 | 130.93 | 132.34 |
| 02 Fri Oct | 140.06 | 130.57 | 132.17 |
| 01 Thu Oct | 139.19 | 130.17 | 132.01 |
| 30 Wed Sep | 140.89 | 129.81 | 131.87 |
| 29 Tue Sep | 140.97 | 129.39 | 131.69 |
| 28 Mon Sep | 142.44 | 128.97 | 131.5 |
Protagonist Therapeutics (PTGX) moving average of 200 SMA is at 111.73 and 200 EMA is at 115.74
| Date | Closing Price | 200 SMA | 200 EMA |
| 05 Mon Oct | 140.63 | 111.73 | 115.74 |
| 02 Fri Oct | 140.06 | 111.45 | 115.49 |
| 01 Thu Oct | 139.19 | 111.2 | 115.24 |
| 30 Wed Sep | 140.89 | 110.96 | 115 |
| 29 Tue Sep | 140.97 | 110.73 | 114.74 |
| 28 Mon Sep | 142.44 | 110.5 | 114.47 |
Protagonist Therapeutics has performed better than Sanofi in short term. Holding Protagonist Therapeutics could be a better choice for now!
Si Bone has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Si Bone, about 10.03% more returns!
Protagonist Therapeutics has performed better than Redhill Biopharma in short term. Holding Protagonist Therapeutics could be a better choice for now!
Orthofix Medical has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Orthofix Medical, about 7.47% more returns!
Protagonist Therapeutics has performed better than Ocular Therapeutix in short term. Holding Protagonist Therapeutics could be a better choice for now!
Intellia Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Intellia Therapeutics, about 3.88% more returns!
Myriad Genetics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Myriad Genetics, about 47.67% more returns!
Moderna Inc has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Moderna Inc, about 48.45% more returns!
Protagonist Therapeutics has performed better than Kala Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Intuitive Surgical has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Intuitive Surgical, about 19.78% more returns!
Protagonist Therapeutics has performed better than Incyte Corporation in short term. Holding Protagonist Therapeutics could be a better choice for now!
Idexx Laboratories has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Idexx Laboratories, about 4.96% more returns!
Guardant Health has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Guardant Health, about 20.01% more returns!
Protagonist Therapeutics has performed better than Dariohealth Corp in short term. Holding Protagonist Therapeutics could be a better choice for now!
Crispr Therapeutics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Crispr Therapeutics, about 8.35% more returns!
Protagonist Therapeutics has performed better than Anavex Life in short term. Holding Protagonist Therapeutics could be a better choice for now!
Adma Biologics has performed better than Protagonist Therapeutics in short term. You could have earned much better returns by investing in Adma Biologics, about 9.61% more returns!
Protagonist Therapeutics has performed better than Adial Pharmaceuticals in short term. Holding Protagonist Therapeutics could be a better choice for now!
Protagonist Therapeutics Technical analysis of indicators
Price action analysis of Protagonist Therapeutics (PTGX) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Protagonist Therapeutics stock for short term is SELL. Signal strength is Strong and stock is losing momentum.
MACD generated a SELL signal for Protagonist Therapeutics in short term and the sell signal is strong.
Protagonist Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Protagonist Therapeutics in short term but BUY signal is weak.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Protagonist Therapeutics is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 140.71 and Protagonist Therapeutics PTGX stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Protagonist Therapeutics PTGX stock. Volume based technical analysis of Protagonist Therapeutics PTGX stock is negative.
Protagonist Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock PTGX Protagonist Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And PTGX Experts View which covers a lot of information including buying and selling signals
PTGX future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Protagonist Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Protagonist Therapeutics (PTGX) Technical (Analysis) Reports Protagonist Therapeutics ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
